Betamethasone (0.05% w/w) + Gentamicin (0.1% w/w) + Miconazole (2% w/w)

🩺 Quick Overview

A fixed-dose combination topical preparation containing a potent corticosteroid (Betamethasone), an aminoglycoside antibiotic (Gentamicin), and an imidazole antifungal (Miconazole). It is designed for the treatment of inflammatory dermatoses complicated by or at high risk of bacterial and fungal infections, commonly seen in tropical climates like India. It provides anti-inflammatory, antipruritic, antibacterial, and antifungal actions in a single formulation.

Medical Uses

  • Inflammatory dermatoses with secondary bacterial and/or fungal infections (e.g., infected eczema, infected contact dermatitis)
  • Intertriginous candidiasis with significant inflammation (Candidal intertrigo)
  • Tinea corporis, tinea cruris, or tinea pedis with severe inflammation, vesiculation, or risk of bacterial infection

Side Effects

  • Local burning or stinging sensation (especially on broken skin)
  • Itching (Pruritus)
  • Dryness of skin
  • Erythema
  • Contact dermatitis (to any component)

💊 Dosage

Apply a thin film to the affected area 2-3 times daily, or as directed by the physician. Duration should be limited, usually 1-2 weeks, and not exceeding 4 weeks.

🏭 Available Brands

4Derm-GM Cipla Ltd.M-Gel Sun Pharmaceutical Industries Ltd.Zincoderm-GM Macleods Pharmaceuticals Ltd.Betagard-M Aristo Pharmaceuticals Pvt. Ltd.B-Mycin Glenmark Pharmaceuticals Ltd.